Successful Development of Vaccines
News broke last week about the initial success of Merck & Co's experimental vaccine to prevent cervical cancer. Gardasil, a genetically engineered vaccine, blocks infection with two types of human papilloma virus, HPV 16 and 18. This development added to the mood of excitement and air of eager anticipation surrounding the 75-minute workshop given by a leading European expert in vaccine trials.
Articles in this issue
almost 20 years ago
Article
Special Lecture, Networking Dinner, 5 October 2005: Industry Consolidation and the Emerging Shape of R&Dalmost 20 years ago
Article
MEDIDATA SOLUTIONS AND CHINESE STATE FOOD & DRUG ADMINISTRATION HOST E-CLINICAL SEMINAR IN BEIJINGalmost 20 years ago
Article
How to Make Progress with Electronic Data Capture, Current and Future Status of EDC in EuropeNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025